安心交易
不成功退款，无后顾之忧，风险服务升级。
Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.
《当代基因疗法》是一份双月刊的同行评议期刊，面向学术界和工业界的科学家，主要关注与疾病基因和细胞治疗的基础研究和临床应用相关的重大课题。细胞治疗手稿也可以包括应用于疾病时，细胞已被基因改造。《当代基因疗法》发表了关于基因转移和基因表达分析、载体发育、细胞基因工程、动物模型以及基因和细胞治疗在治疗疾病方面的临床应用的最新进展的全面/小型综述和原创研究。目前的基因治疗发表评论和原始研究包含基因和细胞治疗的实验数据。该杂志还包括手稿的技术进步，伦理和监管的考虑基因和细胞治疗。综述应该为读者提供一个全面的评价，任何领域的实验生物学应用于分子医学，这不仅是在一个特定的领域的基因治疗和细胞治疗的意义，而且在其他领域的研究人员的兴趣。我们鼓励作者提供他们自己对未来进展的评估和展望。对于尚未积累大量文献的最新突破性发现，也欢迎评论。这些综述为最近基因治疗实验研究的热点问题提供了一个论坛，主要是为了使临床和基础研究人员都能获得这些结果。含有实验数据的原稿应为原始数据，不得发表。
安心交易
不成功退款，无后顾之忧，风险服务升级。
合规备案认证机构
资质许可齐全，合规经营，用户权益有保障。
正刊保障
刊物在国家新闻出版署网可查，抵制假刊、增刊。
对公账户资金监管
交易均通过对公账户，资金安全有保障。01 选择服务并上传稿件 我们的学术顾问将根据您的需求推荐适合的服务
02 分配资深编辑和同行专家 根据您的服务方案和研究方向，为您分配资深编辑和同行专家
03 交付及反馈 每个环节的服务会在您审阅和确认后进行下一步，根据您的反馈和建议做调整
04 提升稿件质量 我们将基于您的反馈并平衡期刊的投稿要求，为您进一步优化稿件
05 提交投稿 出版专家将在您确认定稿后，为您整理并检查所有必须文件，协助您完成期刊投稿。
06 投稿跟进 及时查询稿件状态，协助您与期刊编辑沟通，根据审稿意见协助修正文章
07 拒稿支持 若期刊拒稿，您可通过拒稿咨询服务发掘稿件的改进方案，并获取365天无限次向同期刊或其他期刊的重投服务
